Hepatocellular carcinoma (HCC), the most common form of liver cancer, is the leading cause of cancer-associated mortality worldwide. Despite this, only limited therapeutic treatments are currently available. However, according to a new study published in the journal Molecular Medicine Report, cannabis may provide a treatment option for the disease.
“The present study aimed to investigate the effects of cannabinoids as novel therapeutic targets in HCC”, states the study’s abstract. Using synethtic cannabinoids on cell lines, researchers found that they inhibited the growth of HCC and led to cell cycle arrest.
“These results suggested that cannabinoid receptor agonists, including WIN, may be considered as novel therapeutics for the treatment of HCC”, researchers conclude.
The study was conducted by researchers at the Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, South China University of Technology and Guangzhou Medical University, Guangzhou. It can be found by clicking here.